Impact of Disease Management on Cost-Effectiveness of Medicare Spending

Mueller C Schur C O'Connell J . Prescription drug spending: the impact of age and chronic disease status. Am J Public Health. 1997 Oct; 87(10):1626–1629.

Medicare Chart Book. 2d edition. Kaiser Henry J. Family Foundation. Fall 2001. http://www.kff.org/. Accessed July 2002.

Medicare program: solicitation for proposals for the demonstration project for disease management for severely chronically ill Medicare beneficiaries with congestive heart failure, diabetes, and coronary heart disease. Federal Register. 2002 February 22; 67(36):8267–8270.

Where the Medicare dollar went, 1980 and 1998. Medicare 2000: 55 years of improving Americans’ health and security. Health Care Financing Administration. http://cms.hhs.gov/statistics/. Accessed July 2002.

Medicare Payment Advisory Commission (MEDPAC). Report to the Congress: Medicare Payment Policy. Washington, DC: Medicare Payment Advisory Commission: March 2002.

Capitation Sourcebook: A Practical Guide to Managing At-Risk Arrangements. Boland P , ed. Berkeley, CA: Boland Healthcare; 1996.

Medicare Payment Advisory Commission (MEDPAC). Report to the Congress: Medicare Payment Policy. Washington, DC: Medicare Payment Advisory Commission; March 1999.

The Medicare program: Medicare and prescription drugs (Fact Sheet). Henry J. Kaiser Family Foundation, March 2002. http://www.kff.org/. Accessed July 2002.

Davis M Poisal J Chulis G Zarabozo C Cooper B . Prescription drug coverage, utilization, and spending among Medicare beneficiaries. Health Aff. 1999 Jan-Feb;18(1):231–243.

Cohen J Chee J . Pharmacy benefit managers’ role in facilitating Medicare beneficiary access to pharmaceutical care. Dis Manage Health Outcomes. 2002; 10(4):221–227.

Cohen J . Are commercial disease managers willing and prepared to enter the Medicare market? Drug Inf J. 2002; 36(2):445–452.

Congressional Budget Office cost estimate: H.R. 4954: Medicare Modernization and Prescription Drug Act of 2002. http://www.cbo.gov/. Accessed July 2002.

Ellrodt G Cook DJ Lee J Cho M Hunt D Weingarten S . Evidence-based disease management. JAMA. 1997 Nov 26;278(20):1687–1692.

Avorn J . Improving drug use in elderly patients: getting to the next level. JAMA. 2001 Dec 12; 286(22):2866–2868.

Health Care Financing Administration. Heart Failure National Project Overview:17. http://www.cmrica.org/healthcare_docs/CHF/chf_cms_description.pdf. Accessed October 2002.

Health Care Financing Administration. Acute Myocardial Infarction National Project Overview:5. http://www.cmri-ca.org/healthcare_docs/AMlnational.pdf. Accessed October 2002.

Brookes L . Hypertension update: ALLHAT—results and reactions—plus new guidelines, new approvals, and the ethics of journal publishing. Medscape Cardiology. 2003;7(1). http://www.medscape.com/viewarticle/447590. Accessed April 2003.

Lichtenberg FR . Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS. Health Aff. 2001 Sep-Oct; 20(5):241–251.

Lichtenberg FR . The benefits and costs of newer drugs: evidence from the 1996 Medical Expenditure Panel survey. National Bureau of Economic Research [NBER working paper No. w8147] March 2001. http://papers.nber.org/papers/W8147. Accessed July 2002.

Robinson JC Casalino LP . Reevaluation of capitation contracting in New York and California. Health Aff. 2001;Suppl Web Exclusives: W11–9. http://www.healthaffairs.org/2004Robinson2.pdf. Accessed July 2002.

Kaiser Family Foundation. Trends and indicators in the changing health care marketplace: chart-book. May 2002. http://www.kff.org/content/2002/3161/marketplace2002_finalc.pdf. Accessed July 2002.

National Committee on Quality Assurance. Disease management accreditation & certification status list, www.ncqa.org/programs/accreditation/DM/dmaccredstatus.htm. Accessed May 28, 2002.

National Committee on Quality Assurance. American Healthways becomes nation's first NCQA-accredited disease management organization. NCQA News. 2002 Jun 10. www.ncqa.org/Communications/News/amhcdmaccred.htm. Accessed June 2002.

Centers for Medicare & Medicaid Services. http://www.hcfa.gov/stats/nhe-oact/tables/t2.html. Accessed June 15, 2002.

Cohen JP . PBMs and a Medicare prescription drug benefit. Food & Drug Law J. 2000; 55(3): 311–320.

Cohen J Chee J . Pharmacy benefit managers and Medicare beneficiary access to prescription drugs. Drug Inf J. 2001; 35(2);569–576.

Complete Disease Management Vendor Listings, December 31, 2001. Wellesley MA: Disease Management Purchasing Consortium & Advisory Council LLC; 2002.

Kennedy health care agenda accepts premise of Rx cost-effectiveness. Pink Sheet. 2002 June 24;64(25):14.

Kennedy EM . Health—America's Forgotten Health Care Agenda: A Call For Action. http://kennedy.senate.gov/spotlightnpc061802.html. Accessed October 2002.

Jackson WA . Age, health, and medical expenditure. Chapter 8 in The Social Economics of Health Care. Davis JB , ed. London and New York: Routledge; 2001:195–218.